<DOC>
	<DOCNO>NCT01152814</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity sub-unit , adjuvanted influenza vaccine administer elderly subject</brief_summary>
	<brief_title>Study Evaluate Safety Immunogenicity Sub-unit Adjuvanted Influenza Vaccine Administered Elderly Subjects , Formulation 2010-2011</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Key Males females volunteer 65 year age old Mentally competent Willing able give write informed consent prior study entry . Able comply study requirement . In general good health Key Any serious chronic acute disease History anaphylactic reaction and/or serious allergic reaction follow vaccination Known suspect impairment/alteration immune function Bleeding diathesis condition associate prolonged bleeding time investigator 's opinion would interfere safety subject Within past 6 month , laboratory confirm influenza disease receive influenza vaccine Fever ( i.e. , axillary temperature ≥38°C ) within last 3 day intend study vaccination Individuals receive vaccine within 4 week prior enrollment study planning receive vaccine within 4 week study vaccine</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Seasonal influenza</keyword>
	<keyword>Vaccine</keyword>
</DOC>